• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有反式几何结构且含羧酸盐配体的新型抗肿瘤活性铂化合物:合成、晶体结构及生物活性

New antitumour active platinum compounds containing carboxylate ligands in trans geometry: synthesis, crystal structure and biological activity.

作者信息

van Zutphen Steven, Pantoja Elena, Soriano Rosario, Soro Carlos, Tooke Duncan M, Spek Anthony L, den Dulk Hans, Brouwer Jaap, Reedijk Jan

机构信息

Leiden Institute of Chemistry, Gorlaeus Laboratories, Leiden University, P.O. Box 9502, 2300, RA Leiden, The Netherlands.

出版信息

Dalton Trans. 2006 Feb 28(8):1020-3. doi: 10.1039/b512357g. Epub 2005 Dec 7.

DOI:10.1039/b512357g
PMID:16474887
Abstract

New asymmetric trans-platinum(II) complexes, composed of an isopropylamine, an azole and two carboxylate leaving groups, are presented. The crystal and molecular structures of one of the complexes has been determined and the cytotoxicity and reactivity with 5'-guanosine monophosphate is reported. The complexes show a reduced reactivity, but no decrease in cytotoxic activity compared to their chloro-counterparts. Furthermore the complexes largely overcome cisplatin resistance, they therefore present an interesting class of antitumour active trans-platinum complexes.

摘要

本文介绍了由异丙胺、唑和两个羧酸离去基团组成的新型不对称反式铂(II)配合物。已确定其中一种配合物的晶体和分子结构,并报道了其细胞毒性以及与5'-鸟苷单磷酸的反应活性。与它们的氯取代类似物相比,这些配合物的反应活性降低,但细胞毒性活性并未降低。此外,这些配合物在很大程度上克服了顺铂耐药性,因此它们是一类有趣的具有抗肿瘤活性的反式铂配合物。

相似文献

1
New antitumour active platinum compounds containing carboxylate ligands in trans geometry: synthesis, crystal structure and biological activity.具有反式几何结构且含羧酸盐配体的新型抗肿瘤活性铂化合物:合成、晶体结构及生物活性
Dalton Trans. 2006 Feb 28(8):1020-3. doi: 10.1039/b512357g. Epub 2005 Dec 7.
2
Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP.三种克服顺铂耐药性的新型不对称反式胺(唑)二氯铂配合物及其与5'-鸟苷酸的反应。
J Inorg Biochem. 2006 Dec;100(12):1955-64. doi: 10.1016/j.jinorgbio.2006.09.015. Epub 2006 Sep 28.
3
New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.新型异构体嗪桥联双核铂(II)配合物可规避对顺铂的交叉耐药性。
J Med Chem. 2003 Mar 27;46(7):1210-9. doi: 10.1021/jm020004+.
4
Platinum(II) compounds bearing bone-targeting group: synthesis, crystal structure and antitumor activity.含骨靶向基团的铂(II)化合物:合成、晶体结构和抗肿瘤活性。
Chem Commun (Camb). 2010 Feb 28;46(8):1212-4. doi: 10.1039/b922222g. Epub 2010 Jan 16.
5
Influence of (hydroxymethyl)pyridine and pyridine-carboxylic acids, in trans-position to the isopropylamine and amine ligands, on the cytotoxicity of platinum complexes.(羟甲基)吡啶和吡啶羧酸在与异丙胺和胺配体处于反位时对铂配合物细胞毒性的影响。
Chem Biodivers. 2008 Oct;5(10):2090-2100. doi: 10.1002/cbdv.200890190.
6
Novel trans-dichloridoplatinum(II) complexes with 3- and 4-acetylpyridine: Synthesis, characterization, DFT calculations and cytotoxicity.新型含3-和4-乙酰基吡啶的二氯铂(II)配合物:合成、表征、密度泛函理论计算及细胞毒性
Eur J Med Chem. 2009 May;44(5):1921-5. doi: 10.1016/j.ejmech.2008.11.004. Epub 2008 Nov 19.
7
Design and biological evaluation of new platinum(II) complexes bearing ligands with DNA-targeting ability.具有DNA靶向能力的新型铂(II)配合物的设计与生物学评价
Inorg Chem. 2014 Dec 1;53(23):12627-34. doi: 10.1021/ic502373n. Epub 2014 Nov 17.
8
Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands.通过乙酰肟而非羟胺配体使抗肿瘤铂配合物的构效关系发生逆转。
Mol Pharmacol. 2007 Jan;71(1):357-65. doi: 10.1124/mol.106.030726. Epub 2006 Oct 18.
9
Synthesis, characterization and cytotoxicity of new platinum(IV) axial carboxylate complexes: crystal structure of potential antitumor agent [PtIV(trans-1R,2R-diaminocyclohexane)trans(acetate)2Cl2].新型羧酸根轴向铂(IV)配合物的合成、表征及细胞毒性:潜在抗肿瘤药物[PtIV(反式-1R,2R-二氨基环己烷)反式(乙酸根)2Cl2]的晶体结构
Bioorg Med Chem. 2000 Mar;8(3):515-21. doi: 10.1016/s0968-0896(99)00313-2.
10
Platinum(II) complexes containing iminoethers: a trans platinum antitumour agent.含亚胺醚的铂(II)配合物:一种反式铂类抗肿瘤剂。
Chem Biol Interact. 1995 Dec 22;98(3):251-66. doi: 10.1016/0009-2797(95)03650-4.

引用本文的文献

1
Fine-Tuning the Activation Mode of an 1,3-Indandione-Based Ruthenium(II)-Cymene Half-Sandwich Complex by Variation of Its Leaving Group.通过改变离去基团来微调基于 1,3-茚二酮的钌(II)-对孟烷半三明治配合物的活化模式。
Molecules. 2019 Jun 27;24(13):2373. doi: 10.3390/molecules24132373.
2
cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339.顺式-四氯二(吲唑)合锇(IV)及其锇(III)类似物:为开发顺式异构体的抗癌药物 KP1019 和/或 NKP1339 铺平道路。
Dalton Trans. 2017 Sep 12;46(35):11925-11941. doi: 10.1039/c7dt02194a.
3
Robust structure and reactivity of aqueous arsenous acid-platinum(II) anticancer complexes.
亚砷酸-铂(II)抗癌配合物水溶液的稳定结构与反应活性
Angew Chem Int Ed Engl. 2013 Oct 4;52(41):10749-52. doi: 10.1002/anie.201303251. Epub 2013 Aug 22.
4
cis-Tetra-chloridobis(1H-imidazole-κN(3))platinum(IV).顺式-四氯双(1H-咪唑-κN(3))铂(IV)
Acta Crystallogr Sect E Struct Rep Online. 2012 May 1;68(Pt 5):m547-8. doi: 10.1107/S1600536812013323. Epub 2012 Apr 4.
5
Towards Antitumor Active trans-Platinum Compounds.迈向具有抗肿瘤活性的反式铂化合物
Eur J Inorg Chem. 2009 Apr 1;2009(10):1293. doi: 10.1002/ejic.200801118.